| Literature DB >> 28469414 |
Seul-A Bae1, Ioannis P Androulakis1,2,3.
Abstract
The feeding and fasting cycles are strong behavioral signals that entrain biological rhythms of the periphery. The feeding rhythms synchronize the activities of the metabolic organs, such as liver, synergistically with the light/dark cycle primarily entraining the suprachiasmatic nucleus. The likely phase misalignment between the feeding rhythms and the light/dark cycles appears to induce circadian disruptions leading to multiple physiological abnormalities motivating the need to investigate the mechanisms behind joint light-feeding circadian entrainment of peripheral tissues. To address this question, we propose a semimechanistic mathematical model describing the circadian dynamics of peripheral clock genes in human hepatocyte under the control of metabolic and light rhythmic signals. The model takes the synergistically acting light/dark cycles and feeding rhythms as inputs and incorporates the activity of sirtuin 1, a cellular energy sensor and a metabolic enzyme activated by nicotinamide adenine dinucleotide. The clock gene dynamics was simulated under various light-feeding phase relations and intensities, to explore the feeding entrainment mechanism as well as the convolution of light and feeding signals in the periphery. Our model predicts that the peripheral clock genes in hepatocyte can be completely entrained to the feeding rhythms, independent of the light/dark cycle. Furthermore, it predicts that light-feeding phase relationship is a critical factor in robust circadian oscillations.Entities:
Keywords: Circadian rhythms; NAD+; SIRT1; clock genes; metabolism
Year: 2017 PMID: 28469414 PMCID: PMC5404903 DOI: 10.1177/1177625017702393
Source DB: PubMed Journal: Gene Regul Syst Bio ISSN: 1177-6250
Figure 1.Schematic representation of the light- and feeding-entrained model. The HPA axis is entrained to the light/dark cycle, and NAD+ availability is entrained to food availability. Cortisol and SIRT1 in the periphery entrain the peripheral clock genes. HPA indicates hypothalamic-pituitary-adrenal; NAD+ nicotinamide adenine dinucleotide; SIRT, sirtuin 1.
Parameter values and descriptions.
| No. | Parameter | Value | Units | Description/reference |
|---|---|---|---|---|
| 1 |
| 0.7965 | µM h−1 | Rate constant of CRH production[ |
| 2 |
| 1.0577 | µM | Dissociation constant for CRH production[ |
| 3 |
| 0.5084 | µM h−1 | Rate of CRH enzymatic degradation[ |
| 4 |
| 1.9627 | µM | Michaelis constant of CRH enzymatic degradation[ |
| 5 |
| 0.15 | µM−1 | Efficiency of |
| 6 |
| 0.6857 | µM h−1 | Rate of ACTH production[ |
| 7 |
| 1.0577 | µM | Dissociation constant for ACTH production[ |
| 8 |
| 0.5129 | µM h−1 | Rate of ACTH enzymatic degradation[ |
| 9 |
| 0.3069 | µM | Michaelis constant of ACTH enzymatic degradation[ |
| 10 |
| 1.0302 | µM h−1 | Rate of F central production/estimated[ |
|
|
|
|
| |
| 12 |
| 0.3618 | µM h−1 | Rate of F central enzymatic degradation[ |
| 13 |
| 0.4695 | µM | Michaelis constant of F central enzymatic degradation[ |
| 14 |
| 2.9 | fmol g−1 h−1 | Synthesis rate or glucocorticoid receptor mRNA[ |
| 15 |
| 26.2 | nmol L−1 mg protein−1 | Concentration of FR(N) at which mRNA, |
|
| 540.7 | nmol L−1 mg protein−1 | Baseline value of free cytosolic glucocorticoid receptor[ | |
|
| 25.8 | fmol g−1 | Baseline value of glucocorticoid receptor mRNA[ | |
| 16 |
| Degradation rate of glucocorticoid receptor mRNA[ | ||
| 17 |
| ( | Synthesis rate of free cytosolic receptor[ | |
| 18 |
| 0.49 | Fraction of cortisol recycled[ | |
| 19 |
| 0.57 | h−1 | Rate of receptor recycling from nucleus to cytoplasm[ |
| 20 |
| 0.00329 | L nmol−1 h−1 | Second-order rate constant of glucocorticoid receptor binding[ |
| 21 |
| 0.0572 | h−1 | Degradation rate of cytosolic glucocorticoid receptor[ |
| 22 |
| 0.63 | h−1 | Rate of receptor translocation to the nucleus[ |
| 23 |
| 0.25 | h | Delay in cortisol production following ACTH stimulation |
| 24 |
| 0.34 | nM h−1 | Base transcription rate of MR[ |
| 25 |
| 1.1011 | 1 | Maximum extent of Fperiphery-mediated activation of MR[ |
| 26 |
| 0.5 | nM | Michaelis constant for Fperiphery-mediated activation of MR[ |
| 27 |
| 1.45 | nM | Total MR concentration[ |
| 28 |
| 0.21 | nM | Michaelis constant for MR production[ |
| 29 |
| 0.70 | nM.h−1 | Degradation rate for MR[ |
| 30 |
| 1.65 | nM | Michaelis constant for degradation of MR[ |
| 31 |
| 0.00329 | nM−1 h−1 | Degradation rate for cortisol/mineralocorticoid receptor binding[ |
| 32 |
| 1 | L nmol−1 h−1 | Second order rate constant of mineralocorticoid and receptor binding[ |
| 33 |
| 1 | h−1 | Rate of mineralocorticoid receptor translocation to the nucleus[ |
| 34 |
| 1 | h−1 | Rate of mineralocorticoid receptor recycling from nucleus to cytoplasm[ |
| 35 |
| 1.18 | nM h−1 | Base transcription rate of GR[ |
| 36 |
| 15 | 1 | Maximum extent of Fperiphery-mediated activation of GR[ |
| 37 |
| 30 | nM | Michaelis constant for Fperiphery-mediated activation of GR[ |
| 38 |
| 1.81 | nM | Total GR concentration[ |
| 39 |
| 0.74 | nM | Michaelis constant for GR production[ |
| 40 |
| 1.52 | nM h−1 | Degradation rate for GR[ |
| 41 |
| 1.05 | nM | Michaelis constant for degradation of GR[ |
| 42 |
| 0.00329 | nM−1 h−1 | Degradation rate for cortisol/glucocorticoid receptor binding[ |
| 43 |
| 1 | L nmol−1 h−1 | Second-order rate constant of mineralocorticoid and receptor binding[ |
| 44 |
| 1 | h−1 | Rate of mineralocorticoid receptor translocation to the nucleus[ |
| 45 |
| 1 | h−1 | Rate of mineralocorticoid receptor recycling from nucleus to cytoplasm[ |
| 46 |
| 0.61 | µM h−1 | Base transcription rate of mRNARP[ |
| 47 |
| 0.8 | 1 | Maximum extent of FMR(N)-mediated transcription of mRNARP[ |
| 48 |
| 0.5 | µM | Michaelis constant for FMR(N)-mediated transcription of mRNARP[ |
| 49 |
| 0.3 | 1 | Maximum extent of BMAL1-mediated suppression of mRNAP and mRNATLR4 estimated |
| 50 |
| 25 | µM | Michaelis constant for BMAL1-mediated suppression of mRNAP and mRNATLR4 estimated |
| 51 |
| 0.19 | h−1 | Degradation rate of mRNARP[ |
| 52 |
| 0.29 | h−1 | Translation rate of P[ |
| 53 |
| 1.06 | h−1 | Degradation rate of P[ |
| 54 |
| 0.61 | µM h−1 | Base transcription rate of mRNARP[ |
| 55 |
| 0.8 | 1 | Maximum extent of FMR(N)-mediated transcription of |
| 56 |
| 0.19 | h−1 | Degradation rate of mRNARP[ |
| 57 |
| 1.11 | h−1 | Translation rate of RP[ |
| 58 |
| 0.14 | µM−1 h−1 | PR binding rate constant[ |
| 59 |
| 0.26 | h−1 | Degradation rate of RP[ |
| 60 |
| 1.3 | h−1 | Dissociation rate of PR[ |
| 61 |
| 9 | nM h−1 | Maximal rate of |
| 62 |
| 1 | nM | Michaelis constant of |
| 63 |
| 0.56 | nM | Inhibition constant of |
| 64 |
| 0.01 | nM | Concentration of constitutive activator[ |
| 65 |
| 8 | Hill coefficient of inhibition of | |
| 66 |
| 1.2 | nM−1 | Efficiency of P on transcription of |
| 67 |
| 0.009 | nM h−1 | Coupling strength/estimated |
| 68 |
| 0.12 | h−1 | Degradation rate of |
| 69 |
| 0.3 | nM−1 h−1 | Complex formation rate of |
| 70 |
| 2 | No. of PER/CRY complex forming subunits[ | |
| 71 |
| 0.05 | h−1 | Degradation rate of cytoplasmatic PER/CRY[ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 75 |
| 3.6 | nM h−1 | Maximal rate of |
| 76 |
| 2.16 | nM | Michaelis constant of |
| 77 |
| 3 | Hill coefficient of activation of | |
| 78 |
| 0.75 | h−1 | Degradation rate of |
| 79 |
| 0.24 | h−1 | Translation rate of BMAL1[ |
| 80 |
| 0.06 | h−1 | Degradation rate of cytoplasmatic BMAL1[ |
| 81 |
| 0.45 | h−1 | Nuclear import rate of BMAL1[ |
| 82 |
| 0.06 | h−1 | Nuclear export rate of BMAL1[ |
| 83 |
| 0.12 | h−1 | Degradation rate of nuclear BMAL1[ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviations: ACTH, adrenocorticotropin; CRH, corticotropin-releasing hormone; GR, glucocorticoid receptor; mRNA, messenger RNA; NAD+, nicotinamide adenine dinucleotide; NAM, nicotinamide; NAMPT, nicotinamide phosphoribosyltransferase; NMN, nicotinamide mononucleotide; SIRT1, sirtuin 1.
Bold parameters are estimated.
Figure 2.The time profiles of key components throughout the day upon synchronized (black dotted line) and antisynchronized (blue line) light and feeding schedules. Light signal was at 1 from 6 am to 6 pm and at 0 for the rest of the day. (A) Feeding signals synchronized and antisynchronized to light, (B) corresponding cortisol, (C) PER/CRY protein, and (D) SIRT1 profiles. SIRT indicates sirtuin 1.
Figure 3.Time profiles of key components under constant light schedule at different intensities are compared. (A) Feeding signal was at 1 from 6 am to 6 pm and at 0 for the rest of the day. Constant light signals at different intensities, along with a control, in which feeding and light are synchronized. (B) Cortisol, (C) PER/CRY protein, and (D) SIRT1 profiles under the different light intensities. SIRT1 indicates sirtuin 1.
Figure 4.Number of days taken to first reach the steady-state phase angle upon feeding inversion at different light schedules. L/D is a 12-hour light, 12-hour dark cycle. D/D is a 24-hour dim light schedule with an intensity of 0.1. L/L is a 24-hour light schedule with an intensity of 1. D/D indicates dark light intensity; L/D, light/dark cycle; L/L, bright light intensity.
Figure 5.(A) Amplitude and phase of cortisol, (B) PER/CRY protein, and (C) SIRT1 at various light-feeding phase relations. Thick lines represent data with 12-hour feeding duration with an amplitude of 1, and thin dashed lines represent data with 6-hour feeding duration with an amplitude of 2. SIRT1 indicates sirtuin 1.
Figure 6.(A) Amplitudes of cortisol and (B) PER/CRY proteins at different feeding delay times relative to light.
Figure 7.Sensitivity coefficients for PER/CRY protein under synchronized and antisynchronized light and feeding signals. Sensitivity coefficients were calculated based on PER/CRY amplitude and phase angles.